Miromatrix Medical Stock Debt To Equity
Miromatrix Medical fundamentals help investors to digest information that contributes to Miromatrix Medical's financial success or failures. It also enables traders to predict the movement of Miromatrix Stock. The fundamental analysis module provides a way to measure Miromatrix Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Miromatrix Medical stock.
Miromatrix |
Miromatrix Medical Company Debt To Equity Analysis
Miromatrix Medical's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Miromatrix Medical Debt To Equity | 0.1 % |
Most of Miromatrix Medical's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Miromatrix Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
CompetitionAccording to the company disclosure, Miromatrix Medical has a Debt To Equity of 0.095%. This is 99.82% lower than that of the Biotechnology sector and 99.51% lower than that of the Health Care industry. The debt to equity for all United States stocks is 99.8% higher than that of the company.
Miromatrix Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Miromatrix Medical's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Miromatrix Medical could also be used in its relative valuation, which is a method of valuing Miromatrix Medical by comparing valuation metrics of similar companies.Miromatrix Medical is currently under evaluation in debt to equity category among its peers.
Miromatrix Fundamentals
| Return On Equity | -1.14 | |||
| Return On Asset | -0.56 | |||
| Operating Margin | (593.69) % | |||
| Current Valuation | 80.11 M | |||
| Shares Outstanding | 27.42 M | |||
| Shares Owned By Insiders | 23.95 % | |||
| Shares Owned By Institutions | 25.75 % | |||
| Number Of Shares Shorted | 11.66 K | |||
| Price To Book | 5.98 X | |||
| Price To Sales | 97.02 X | |||
| Revenue | 953.47 K | |||
| Gross Profit | (466.93 K) | |||
| EBITDA | (29.91 M) | |||
| Net Income | (29.96 M) | |||
| Cash And Equivalents | 32.67 M | |||
| Cash Per Share | 1.56 X | |||
| Total Debt | 3.55 M | |||
| Debt To Equity | 0.1 % | |||
| Current Ratio | 9.09 X | |||
| Book Value Per Share | 0.57 X | |||
| Cash Flow From Operations | (26.68 M) | |||
| Short Ratio | 0.03 X | |||
| Earnings Per Share | (1.14) X | |||
| Target Price | 3.13 | |||
| Number Of Employees | 76 | |||
| Beta | 0.015 | |||
| Market Capitalization | 92.95 M | |||
| Total Asset | 34.76 M | |||
| Retained Earnings | (104.01 M) | |||
| Working Capital | 22.36 M | |||
| Z Score | 9.47 | |||
| Net Asset | 34.76 M |
Pair Trading with Miromatrix Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Miromatrix Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Miromatrix Medical will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Gilead Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Gilead Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Gilead Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Gilead Sciences to buy it.
The correlation of Gilead Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Gilead Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Gilead Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Gilead Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Miromatrix Stock
If you are still planning to invest in Miromatrix Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Miromatrix Medical's history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |